Senseonics Holdings (SENS)

• Market cap: $487M
• 1 day: -0.65%
• 5 days: 1.17%
• 1 month: 13.50%
• 3 months: -31.68%
• 6 months: 117.62%
• Year to date: 57.41%
• 1 year: 52.92%
• 5 years: 30.65%
• 10 years: -73.87%
• Sector: Technology
• Industry: Scientific & Technical Instruments

About: Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Employees: 117

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

101% more capital invested

Capital invested by funds: $20.8M [Q3] → $41.8M (+$21M) [Q4]

98% more call options, than puts

Call options by funds: $324K | Put options by funds: $164K

56% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 18

2.34% more ownership

Funds ownership: 11.08% [Q3] → 13.41% (+2.34%) [Q4]

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

5% less funds holding

Funds holding: 129 [Q3] → 123 (-6) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $2 169% upside
• Avg. target: $2 169% upside
• High target: $2 169% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Mizuho Anthony Petrone 45% 1-year accuracy 10 / 22 met price target	169% upside $2	Outperform Initiated	10 Apr 2025
HC Wainwright & Co. Vernon Bernardino 24% 1-year accuracy 17 / 70 met price target	169% upside $2	Buy Reiterated	5 Mar 2025